Minimal Clinically Important Difference of Tinnitus Outcome Measurement Instruments—A Scoping Review
Journal of Clinical Medicine · 15.11.2023 · 12 (22) · 7117
DOI: 10.3390/jcm12227117 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.11.2023. Verfasst von Berthold Langguth und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, Bezirksklinikum, University of Regensburg, 93053 Regensburg, Germany. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Regensburg.
Abstract (Originalsprache)
Objective
Tinnitus assessment and outcome measurement are complex, as tinnitus is a purely subjective phenomenon. Instruments used for the outcome measurement of tinnitus in the context of clinical trials include self-report questionnaires, visual analogue or numeric rating scales and psychoacoustic measurements of tinnitus loudness. For the evaluation of therapeutic interventions, it is critical to know which changes in outcome measurement instruments can be considered as clinically relevant. For this purpose, the concept of the minimal clinically important difference (MCID) has been introduced. Study design: Here we performed a literature research in PubMed in order to identify for which tinnitus outcome measurements MCID criteria have been estimated and which of these estimates fulfil the current methodological standards and can thus be considered as established.
Results
For most, but not all tinnitus outcome instruments, MCID calculations have been performed. The MCIDs for the Tinnitus Handicap Inventory (THI), the Tinnitus Questionnaire (TQ), the Tinnitus Functional Index (TFI) and visual analogue scales (VAS) vary considerably across studies. Psychoacoustic assessments of tinnitus such as loudness matching have not shown sufficient reliability and validity for the use as an outcome measurement.
Conclusion
Future research should aim at the confirmation of the available estimates in large samples involving various therapeutic interventions and under the consideration of time intervals and baseline values. As a rule of thumb, an improvement of about 15% can be considered clinically meaningful, analogous to what has been seen in other entirely subjective pathologies like chronic pain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Psychotherapy, Bezirksklinikum, University of Regensburg, 93053 Regensburg, Germany.
- Section of Neurosurgery, Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.
Förderung
- University of Regensburg
Zitieren
APA
Langguth, B., & De Ridder, D. (2023). Minimal Clinically Important Difference of Tinnitus Outcome Measurement Instruments—A Scoping Review. Journal of Clinical Medicine, 12(22), 7117. https://doi.org/10.3390/jcm12227117
Vancouver
Langguth B, De Ridder D. Minimal Clinically Important Difference of Tinnitus Outcome Measurement Instruments—A Scoping Review. Journal of Clinical Medicine. 2023;12(22):7117. doi:10.3390/jcm12227117
BibTeX
@article{Langguth2023,
author = {Langguth, Berthold and De Ridder, Dirk},
title = {Minimal Clinically Important Difference of Tinnitus Outcome Measurement Instruments—A Scoping Review},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {22},
pages = {7117},
doi = {10.3390/jcm12227117}
}
EUVIMED